One characteristic of atherosclerosis is the accumulation of lipid-laden macrophage foam cells in the arterial wall. We have previously shown that the binding of oxidized low-density lipoprotein (oxLDL) to the scavenger receptor CD36 activates the kinase Lyn, initiating a cascade that inhibits macrophage migration and is necessary for foam cell generation. We identified the plasma membrane ion transporter Na 
INTRODUCTION
The formation of lipid-laden foam cells from differentiated monocytes or macrophages is a hallmark of atherosclerosis (1) . A key step during this process is the binding of oxidized low-density lipoprotein (oxLDL) to macrophage surface scavenger receptors such as CD36 and scavenger receptor A, leading to internalization of lipoproteins and overloading of lipids within the cells (2, 3) . Although the cell surface receptors that recognize oxLDL have been extensively characterized, the downstream signaling events responsible for oxLDL-mediated macrophage phenotypes remain incompletely defined. Our laboratory has reported that 60 to 70% of oxLDL uptake by murine macrophages is mediated by CD36 (3) and that CD36 facilitates oxLDL uptake by recruiting and activating an intracellular signaling complex including the Src family kinase (SFK) Lyn. Pharmacologic blockade of SFKs attenuates foam cell formation induced by oxLDL, which suggests that Lyn activation is essential for oxLDL uptake and lipid overloading (4) . Additionally, we have shown that Lyn activation contributes to oxLDL-induced loss of macrophage polarization (5) and inhibition of migration, thereby contributing to foam cell accumulation in the arterial intima (6) . However, because CD36 has very short cytosolic domains without known enzymatic activities and scaffolding functions (7) , it remains a question as to how CD36 initiates Lyn activation.
The Na + /K + -ATPase (NKA) is an ion transporter (8) that is also a signal transducer (9) . The functional NKA molecule consists of a and b subunits. The b subunit mediates folding and trafficking of the whole enzyme to the plasma membrane (10) , and the a subunit contains nucleotide, cation, and ligand-binding sites as well as binding motifs to other signaling proteins including Src (11) . The NKA a1 subunit interacts with SFKs through multiple domains and can switch kinase activity off or on (11) (12) (13) . NKA can also regulate cellular cholesterol concentrations and distribution through its ability to interact with various cytosolic and membrane proteins (14) . Because we have shown that CD36 interacts with NKA in macrophages (15) , we hypothesized that CD36 uses NKA to regulate the kinase activity of Lyn and its downstream signaling in response to oxLDL. Here, we showed that NKAwas required for the activation of Lyn by the oxLDL-CD36 complex. We used an NKA a1 subunit gene (Atp1a1) deletion mouse model in which~60% of the expression of the gene encoding NKA a1 was absent in macrophages to demonstrate that decreased abundance of NKA in macrophages prevented Lyn activation and downstream signaling induced by oxLDL. Partial Atp1a1 deficiency in macrophages was associated with attenuated oxLDL uptake, reduction in foam cell formation, and loss of the oxLDL-inhibited migratory phenotype. Knockdown of NKA a1 by small interfering RNA (siRNA) in human monocyte-derived macrophages also showed that NKA a1 was important for oxLDL and cholesterol uptake and foam cell formation. Finally, we generated a new genetic mouse model (Apoe −/− NKA a1 +/− ) and used bone marrow transplantation to show that reduction of NKA a1 in macrophages protected mice from diet-induced atherosclerosis.
RESULTS
CD36 recruits a signaling complex that includes NKA and Lyn in response to oxLDL CD36 was precipitated from peritoneal macrophage lysates from wildtype C57BL/6 mice, and NKA, Lyn, activated Lyn (phosphorylated at Tyr 396 ), and CD36 were then detected and quantified by immunoblot. We found that CD36 coprecipitated with NKA as well as with Lyn under basal conditions (Fig. 1A ). Pretreating cells with oxLDL triggered recruitment of about 50% more NKA and Lyn to the complex and led to Lyn activation, consistent with our previous findings (4, 15) . We also found that NKA constitutively interacted with Lyn in wild-type macrophages, an interaction that was not affected by oxLDL treatment (Fig. 1B) , suggesting that CD36 recruited the NKA-Lyn complex when bound to oxLDL.
To test the capability of NKA to regulate Lyn kinase activity, we incubated NKA purified from pig kidneys with Lyn in vitro in the presence of ATP. Kinase activity was measured by immunoblot with an antibody specific for the active tyrosine phosphorylation site (Tyr 396 ). NKA inhibited Lyn activity in a dose-dependent manner (Fig. 1C , lanes 2 to 5), consistent with a previously published study showing that NKA binds to and inhibits Src (11) . To test whether NKA regulates Lyn in macrophages, we assessed Lyn activation in NKA immunoprecipitates from murine peritoneal macrophages that had been exposed to the NKA-activating ligand ouabain and found that ouabain increased the amount of total and phosphorylated Lyn associated with NKA ( Fig. 1,  D 
to F).
The oxLDL-CD36 signaling axis requires NKA To test our hypothesis that CD36 uses NKA to regulate Lyn kinase activity in response to oxLDL, we used a genetic mouse model in which one allele of the gene encoding the NKA a1 subunit (Atp1a1) is inactivated (16) . Whereas homozygous null mice die early in embryonic development, heterozygous null mice are viable and fertile with no obvious growth defect or health issues (16) and no differences in macrophage mobilization to the peritoneal cavity in response to thioglycollate, a nonspecific agent that recruits inflammatory cells to the peritoneal cavity (17) . We detected a~60% reduction in NKA a1 protein abundance in heterozygous null (referred to as NKA a1 +/− ) macrophages compared to control cells (referred to as NKA a1 +/+ ) without overt changes in CD36 and Lyn abundance ( fig. S1A ). oxLDL treatment did not induce the interaction of NKA and Lyn with CD36 in NKA a1 +/− macrophages, and activated Lyn was not detected in the anti-CD36 precipitates from NKA a1 +/− macrophages ( Fig. 2A ). To show that NKA functions downstream of CD36, we used macrophages isolated from Cd36-null mice. These cells showed similar amounts of NKA a1 or Lyn as control cells ( fig. S1B ), but oxLDL did not induce the association of activated Lyn with NKA ( Fig. 2B ) in Cd36-null macrophages.
Because the guanine nucleotide exchange factor Vav functions downstream of oxLDL-CD36-Lyn signaling and is required -Lyn, total Lyn, and NKA a1. Cell lysates were probed with anti-NKA a1 and anti-Lyn to show similar amounts of the two proteins in the inputs for immunoprecipitation. Quantified data from (D) are shown in (E) and (F) (n = 4 independent experiments). *P < 0.05. **P < 0.01. Significance was determined by analysis of variance (ANOVA) analysis.
for CD36-mediated foam cell formation (18, 19) and CD36-mediated inhibition of migration (5), we examined Vav activation by oxLDL in NKA-deficient cells. oxLDL treatment led to a threefold increase in tyrosine-phosphorylated Vav in NKA a1 +/+ macrophages but not in NKA a1 +/− cells (Fig. 2C ), indicating that NKA is essential for oxLDL-CD36-Lyn-Vav signaling cascades.
NKA plays a role in oxLDL uptake and foam cell formation
To assess the role of NKA signaling functions in CD36-mediated oxLDL uptake, we exposed NKA a1 +/+ or NKA a1 +/− macrophages to DiI-tagged oxLDL (DiI-oxLDL) at 4°C to measure binding (internalization is blocked at 4°C) or at 37°C to measure internalization of oxLDL. oxLDL binding appeared to be similar in NKA a1 +/− and NKA a1 +/+ macrophages (Fig. 3A) , consistent with the immunoblot data showing that CD36 abundance was comparable between NKA a1 +/+ and NKA a1 +/− macrophages (fig. S1A). oxLDL uptake at 37°C, however, was significantly attenuated in NKA a1 +/− macrophages (Fig. 3 , B and C), suggesting that NKA is important for oxLDL uptake in macrophages.
To confirm the data obtained with DiI-oxLDL, we also measured cellular cholesterol content. Although basal cholesterol content did not differ significantly in NKA a1 +/+ and NKA a1 +/− macrophages ( fig. S1C ), treatment with oxLDL resulted in significantly attenuated cholesterol loading of the NKA a1 +/− compared to NKA a1 +/+ cells (Fig. 3D ). Similar to NKA a1 +/− macrophages, Cd36-null macrophages showed~25% less cholesterol uptake compared to control cells after oxLDL treatment (Fig. 3E) . Additionally, we measured cholesterol efflux through ABCA1 or ABCG1, the two major lipid transporter proteins mediating cholesterol efflux in macrophages (20) . Comparable amounts of cellular free cholesterol were released through ABCA1 or through ABCG1 in NKA a1 +/+ and NKA a1 +/− macrophages ( fig. S1D ). These data indicate that NKA a1 reduction in macrophages specifically decreased oxLDL and cholesterol uptake, leaving ABCA1-or ABCG1-mediated cholesterol efflux intact.
Oil Red O staining revealed that oxLDL treatment induced the formation of fewer foam cells from NKA a1 +/− macrophages than from NKA a1 +/+ macrophages ( Fig. 3 , F and G). Furthermore, oxLDL treatment increased cellular cholesterol content to a lesser extent in NKA a1 +/− macrophages than in NKA a1 +/+ macrophages ( Fig.  3H ). To rule out the possibility that NKA a1 reduction leads to a general internalization defect in macrophages, we measured the uptake of DiI-labeled acetylated LDL, which is mainly mediated by scavenger receptor A, rather than CD36 (21), and found no significant difference in uptake between NKA a1 +/+ and NKA a1 +/− macrophages (fig. S1E). Increases in total cellular cholesterol content and viability as assessed by apoptosis assays were also similar (fig. S1, F and G).
Because NKA a1 +/+ and NKA a1 +/− mice are from a mixed genetic background (C57BL/6 plus Black Swiss), it is possible that unknown "passenger" genes around the Atp1a1 locus could contribute to the above phenotypes. We therefore repeated some of the assays in human monocytederived macrophages transfected with siRNA directed against NKA a1, which showed a 60% reduction in NKA a1 abundance, increased CD36 abundance, and no change in Lyn abundance ( fig. S2A ). We first showed that oxLDL induced the formation of a protein complex consisting of CD36, NKA a1, and Lyn ( fig. S2B ), a similar phenomenon as observed in mouse peritoneal macrophages (Fig. 1A) . Moreover, oxLDL-induced Lyn activation was attenuated in NKA a1 knockdown human macrophages (f ig. S2C). Although NKA a1 knockdown macrophages had higher CD36 abundance, they took up 50% less oxLDL compared to macrophages transfected with control siRNA (Fig. 4, A and B) , similar to what we observed in NKA a1 +/− mouse macrophages (Fig. 3 , B and C). In addition, foam cell formation (Fig. 4C ) and cholesterol loading (Fig. 4D) were reduced in NKA a1 knockdown macrophages.
NKA contributes to oxLDL-induced inhibition of macrophage migration
We have previously shown that the oxLDL-CD36-Lyn signaling axis leads to dysregulated activation of focal adhesion kinase (FAK) and disruption of myosin dynamics, leading to loss of cellular polarity, increased cell spreading, and inhibition of migration (6) . We therefore tested whether NKA plays a role in FAK activation. oxLDL increased the phosphorylation of FAK by 2.4-fold in NKA a1 +/+ macrophages, but not in NKA a1 +/− macrophages ( Fig. 5A) , demonstrating that the enhanced FAK activation induced by oxLDL-CD36 signaling requires NKA. Consistent with loss of FAK activation, oxLDL-induced enhanced cell spreading was not seen in NKA a1 +/− macrophages (Fig. 5B) . We also examined macrophage motility in vitro using a modified Boyden chamber and found that compared to untreated cells, NKA a1 +/+ macrophage migration was reduced by oxLDL, but not by native LDL, and that the inhibitory effect of oxLDL on migration was significantly attenuated in NKA a1 +/− cells compared to NKA a1 +/+ cells (Fig. 5C ).
Deficiency of NKA a1 in macrophages protects mice from diet-induced atherosclerosis
To show the pathophysiological relevance of our findings, we generated a mouse line heterozygous null for the Atp1a1 allele on an Apoe-null background (22) . As expected, NKA a1 abundance was reduced bỹ 60% in Apoe −/− NKA a1 +/− macrophages compared to Apoe −/− NKA a1 +/+ macrophages, whereas CD36 and Lyn abundance showed no obvious differences ( fig. S2D ). We assessed atheroma formation by en face evaluation of aortae from mice on a high-fat diet. Apoe −/− NKA a1 +/− mice showed a 55% reduction in plaque area (10.9 ± 1.5% covered) compared to Apoe −/− NKA a1 +/+ littermates (23.7 ± 2.4%) (Fig. 6A ). This phenotype was not due to differences in plasma lipid content because plasma total fasting cholesterol and triglyceride concentrations were comparable in both groups ( fig. S3A ). Furthermore, body weights after high-fat diet feeding were similar between the two groups ( fig. S3B ). Oil Red O staining of cryosections of the aorta roots at the level of the aortic sinus revealed that the mean crosssectional lesion area was reduced by~43% in the Apoe −/− NKA a1 +/− mice compared to controls (Fig. 6B) . Immunostaining revealed a significantly lower signal for the macrophage marker MOMA-2 in Apoe −/− NKA a1 +/− lesions (Fig. 6C ) but no differences in a-smooth muscle actin staining ( fig. S3C) .
To demonstrate that macrophage NKA function is important for dietinduced atherosclerosis, we performed bone marrow transplantation using Apoe −/− mice subjected to g-irradiation as recipients and either Apoe 6D ). These in vivo results are consistent with our hypothesis that NKA contributes to macrophage-derived foam cell formation and atherosclerosis development.
DISCUSSION
Atherosclerotic plaques in the arterial wall accumulate macrophage-derived foam cells. A critical step for conversion of macrophages to foam cells is the internalization of modified lipoproteins, including oxLDL. These lipid-laden cells lose their motility and become "stuck" in the arterial intima where they contribute to lesion development by producing inflammatory mediators; they eventually undergo apoptosis and contribute to a necrotic core within atherosclerotic plaques. We have reported that binding of oxLDL to its receptor CD36 plays a critical role in these processes (4, 6) by activating intracellular signaling cascades including SFKs (such as Lyn). Here, we identified NKA as a crucial binding partner of CD36 that promotes Lyn activation in response to oxLDL. We showed that oxLDL binding to CD36 recruited and activated Lyn through NKA. Decreased NKA a1 abundance in macrophages resulted in a significant decrease in oxLDL uptake, foam cell formation, and oxLDL-induced inhibition of cell migration. Because NKA a1 is abundant in macrophages and its role in cation homeostasis is essential, an alternative explanation for reduced oxLDL uptake in NKA a1 +/− cells is that NKA a1 reduction caused a general defect in macrophage function. However, NKA a1 +/− macrophages had normal morphology, viability, cholesterol efflux, migration in vitro, and internalization of acetylated LDL. We showed that NKA a1 in bone marrow-derived macrophages contributed to diet-induced atherosclerosis in Apoe-null mice. However, because the Atp1a1 heterozygous mice are from a mixed genetic background (C57BL/6 and Black Swiss), our in vitro and in vivo experiments using macrophages from these mice cannot rule out passenger gene effects and should be interpreted with caution. Nevertheless, our studies in siRNAtransfected human macrophages support a role for NKA in oxLDL uptake and foam cell formation (Fig. 4) . On the basis of our data, we propose a model (Fig. 7) in which CD36 converts extracellular oxLDL signals to intracellular Lyn activation through ligand-dependent recruitment of NKA, which functions as an on and off switch for SFKs. The mechanism by which NKA regulates SFKs has been characterized by Xie and colleagues. Under basal conditions, NKA interacts with and "covers" the kinase domain of SFKs to hold them in an inactive state. A conformational change in NKA, such as that induced by binding of cardiotonic steroids, results in the release of the kinase domain and subsequent activation (11, 23) . Thus, the potential molecular mechanism for Lyn activation by oxLDL may be that CD36 binding alters the conformation of NKA, leading to release of Lyn kinase domain. This proposition is supported by the findings that NKA and Lyn were both recruited to CD36 in response to oxLDL (Fig. 1A) , and Lyn activation by oxLDL was abolished when NKA abundance was reduced to 60% or when CD36 was absent (Fig. 2) . Consistent with this model is our observation that macrophages with 60% NKA reduction share similar phenotypes with Cd36-null macrophages in response to oxLDL, including (i) abolished Lyn activation and the downstream activation of Vav and FAK (4, 6, 18), (ii) diminished oxLDL uptake and cholesterol loading (4), and (iii) decreased cell spreading and attenuated inhibition of cell migration (6). Moreover, partial loss of Atp1a1, similar to Cd36 deficiency (3), protected Apoe-null mice from diet-induced atherosclerosis. Together, these findings indicate that NKA is an indispensable component in the oxLDL-CD36 signaling axis for foam cell formation and migration inhibition and thereby contributes to atherosclerosis.
Although NKA a1 +/− macrophages had some NKA [40% of the amount of NKA as wild-type (NKA a1
) macrophages], they were defective in oxLDL-CD36 signaling events as well as oxLDL uptake. These results may not be surprising because we have previously shown that knockdown of NKA a1 to~45% of the control amount significantly decreases the ability of NKA to activate Src kinase (23) and that there are pools of nonpumping NKA located in the lipid-enriched domains of the plasma membrane and which interacted with other signaling partners including Src (24, 25) . Knockdown of NKA a1 eliminates the nonpumping pool of NKA first because the pumping activity of the NKA is indispensible for cell survival (25) . Therefore, it is possible that the remaining 40% of NKA a1 molecules present in NKA a1 +/− macrophages is adequate to provide normal pumping activity but that at least 40% of the normal amount is required for NKA signaling function.
Like most other scavenger receptors, CD36 has few discernible intracellular signaling motifs or domains, conveys multiple signals to activate various pathways (7, 26) , and may function in heteromultimeric signaling complexes to convey these signals. Various transmembrane proteins, including Toll-like receptors (TLRs), integrins, and tetraspanins, associate with CD36 for different cellular functions (27) (28) (29) (30) (31) . A model in which CD36 and NKA complex formation affects oxLDL signaling is compatible with these data and with previous reports that both CD36 and NKA are enriched in specific membrane microdomains (24, 32) . A study by Heit et al. has uncovered a signaling complex containing CD36, b 1 and b 2 integrins, tetraspanins CD9 and CD81, and the adapter FcRg that enables CD36-mediated oxLDL uptake in peritoneal macrophages (33) . Our findings raise the possibility that NKA is responsible for bringing Lyn to the CD36-associated FcRg, which will require further investigation. Another interesting question is whether NKA facilitates other biological effects downstream of oxLDL-CD36 axis. Seimon et al. have reported that CD36, when paired with TLR2 and TLR6, induces apoptosis in response to oxLDL (34) . We found no significant difference between oxLDL-induced apoptosis in NKA a1 +/+ and NKA a1 +/− macrophages ( fig. S1G ), suggesting that NKA is not an obligate partner for all CD36-mediated functions in response to oxLDL.
We previously reported that NKA is involved in regulating cellular cholesterol concentrations and distribution (14, 35) , and activation of NKAmediated signaling contributes to production of reactive oxygen species (15) . Our current work has now revealed crosstalk between NKA and CD36 signaling in macrophages, which connect oxidant stress, lipoprotein modification, and athero-inflammatory disorders, and link innate immune responses to NKA. A group of endogenous cardiotonic steroids, including ouabain, are endogenous NKA ligands, and their plasma concentrations are increased in human patients with hypertension, congestive heart failure, and diabetes (36) , conditions that are associated with increased risk of atherosclerosis. Because we found that ouabain stimulated NKA-Lyn complex formation in macrophages (Fig. 1D) , it will be important to investigate the effect of ouabain on foam cell generation and atherogenesis in future studies. Additionally, specific blockade of the CD36 and NKA interaction could be a novel therapeutic target for athero-inflammatory disorders. LDL and oxLDL were isolated and prepared as previously described (37) . Ouabain, Oil Red O, and ATP were purchased from Sigma. DiI and the Amplex Red Cholesterol Assay Kit were from Molecular Probes. The Triglyceride Assay Kit was from Cayman Chemical. [ To acquire human macrophages, monocytes were isolated from human buffy coats by Ficoll density centrifugation and allowed to differentiate over 5 days in vitro to macrophages (38) . Transfection of siRNA into human macrophages was performed using Viromer Blue from OriGene according to the manufacturer's manual.
MATERIALS AND METHODS

Antibodies, cells, and other reagents
Experimental animals
C57BL/6 and Apoe-null mice were purchased from the Jackson Laboratory. Cd36-null (3) and Atp1a1 heterozygous mice (16) were generated as previously described. The Atp1a1 heterozygous mice (NKA a1 mice. Then, Apoe +/− NKA a1 +/− males were mated with Apoe +/− NKA a1 +/− females to produce the desired genotypes. Adult mice at~16 to 20 weeks of age were used to isolate peritoneal macrophages as previously described (3) . All mice were kept in a 12-hour dark/light cycle and fed standard chow ad libitum unless indicated otherwise, and all procedures were approved by the Institutional Animal Care and Use Committee at the Medical College of Wisconsin.
Diet-induced atherosclerosis and aortic lesion analysis
Apoe
−/− NKA a1 +/+ mice and littermate Apoe −/− NKA a1 +/− mice were fed a high-fat diet (Harlan Teklad, catalog no. 88137) for 12 weeks to induce atherosclerosis. All mice were sacrificed after a 16-hour starvation period.
Whole blood was isolated from the inferior vena cava, and plasma was subsequently isolated by centrifugation (2800g, 10 min) and subjected to cholesterol and triglyceride measurement. Aortae were dissected and fixed in 4% paraformaldehyde overnight. Lesion surface area was assessed by en face Oil Red O staining as previously described (3, 39) and quantified by MetaMorph software (Molecular Devices). Aortic sinus (the proximal aorta region) was dissected, fixed in 4% paraformaldehyde overnight, and then embedded for cryosection into 10-mm-thick slices. Then, the cryosections were subjected to Oil Red O staining or immunohistochemistry using antibodies for different cell markers.
Bone marrow transplantation
Apoe −/− mice were subjected to full body g-irradiation to eliminate endogenous bone marrow stem cells and bone marrow-derived cells. They were then injected with bone marrow isolated from the femur and tibia of either Apoe −/− NKA a1 +/+ mice or Apoe −/− NKA a1 +/− mice. Bone marrow cells (8 × 10 6 ) were given to each recipient mouse through retro-orbital injection. After bone marrow transplantation, mice were fed a chow diet for 4 weeks to allow for bone marrow reconstitution and then switched to the high-fat diet for an additional 12 weeks to induce atherosclerotic lesion formation.
Foam cell formation
Thioglycollate-elicited peritoneal macrophages were plated on coverslips in 12-well plates in RPMI 1640 medium with 10% fetal bovine serum. Nonadherent cells were washed away 4 hours after plating, and fresh medium was added for additional 24 hours. Cells were then exposed to native LDL or oxLDL (50 mg/ml) for 18 hours. Cells were fixed with 4% paraformaldehyde and stained with Oil Red O.
Binding and uptake of oxLDL
Peritoneal macrophages were plated on coverslips in 12-well plates. Cells were incubated with DiI-labeled oxLDL (10 mg/ml) for 3 hours at 4°C to assess binding. To evaluate oxLDL uptake, cells were incubated with DiI-labeled oxLDL (10 mg/ml) for indicated time points at 37°C before being fixed for imaging study. Fluorescence intensity was examined by confocal microscopy at 60× magnification and quantified by ImageJ software (National Institutes of Health).
Measurement of ABCA1-and ABCG1-mediated free cholesterol efflux
Measurement of free cholesterol efflux from murine macrophages was performed as previously described (40, 41) . Briefly, macrophages were prelabeled with [ 3 H]cholesterol in the presence of oxLDL (50 mg/ml) overnight. Cells were then washed and incubated with a 0.5% bovine serum albumin (BSA)/RPMI solution overnight. For ABCG1-mediated cholesterol efflux, cells were incubated with HDL (50 mg/ml) in 0.5% BSA/RPMI solution for 4 hours. For ABCA1-mediated cholesterol efflux, 200 mM 8-bromoadenosine 3′,5′-cyclic monophosphate was added to the medium to stimulate cellular ABCA1 expression overnight. Cells were then incubated with apolipoprotein A-I (apoA-I; 20 mg/ml) in 0.5% BSA/RPMI solution for 4 hours. After the incubation of HDL or apoA-I, free cholesterol efflux from cells was assessed by counting radioactivity associated with the media and cells.
Protein, cholesterol, and triglyceride assays
After different treatments, cells were lysed in radioimmunoprecipitation assay buffer with a protease inhibitor cocktail (Roche). Protein content was assayed by Protein Assay Kit from Bio-Rad. Cellular cholesterol concentrations were quantified using the Amplex Red Cholesterol Assay Kit (Invitrogen) according to the manufacturer's instructions. Signals were detected by a microplate spectrofluorometer (excitation, 560 nm; cutoff, 570 nm; emission, 590 nm). Triglyceride concentrations in the plasma were measured by a triglyceride assay kit according to the manufacturer's instructions (Cayman).
Immunoprecipitation and immunoblot assays
For immunoprecipitation assays, cells were treated with or without oxLDL (50 mg/ml) for either 20 min (when CD36 and NKA a1 were immunoprecipitated) or 2 min (when Vav was immunoprecipitated). Then, cells were lysed in CelLytic M Cell Lysis Reagent (Sigma) with protease inhibitor cocktail (Roche) and phosphatase inhibitors (Sigma). Cell lysates were precleared with agarose beads (Life Technologies) for 2 hours at 4°C. Cleared supernatant with 1 mg of protein was incubated with 2 mg of primary antibody against indicated proteins for 2 hours at room temperature. Agarose beads were added and incubated overnight at 4°C. Beads were extensively washed with the lysis reagent and boiled in SDS-polyacrylamide gel electrophoresis (PAGE) loading buffer, and the bound materials were analyzed by immunoblot using specific antibodies. For immunoblotting, cells were lysed as above and lysates with equal amounts of proteins were separated in 10% SDS-PAGE gel, transferred to polyvinylidene difluoride membrane, and probed with corresponding antibodies. Protein signals were detected with an ECL kit (Thermo Fisher Scientific) and quantified by ImageJ software.
NKA purification procedure and Lyn kinase activity assay NKA was purified from pig kidney outer medulla as previously described (12) . Preparations with specific activity of 1000 to 1400 mol Pi/mg per hour were used. To determine whether NKA regulated Lyn kinase activity, purified Lyn (20 ng; Millipore) was incubated with different amounts of purified NKA for 30 min in phosphate-buffered saline at 37°C. Afterward, 2 mM ATP/Mg 2+ was added. The reaction continued for 5 min at 37°C and was stopped by addition of SDS sample buffer. Phosphorylated Tyr 396 -Lyn was measured by immunoblot with anti-phosphorylated Tyr 418 antibody (Invitrogen) to indicate Lyn activation (12, 42) .
Cell spreading assay
The cell spreading assay was performed as previously described (6) . Mouse peritoneal macrophages were seeded onto serum-coated coverslips and incubated at 37°C for 30 min to allow the cells to attach to the surface. Cells were then incubated with or without oxLDL (50 mg/ml) for 5 min before fixation with 4% paraformaldehyde and staining with fluoresceinconjugated phalloidin (Invitrogen). Nuclei were stained with 4′,6-diamidino-2-phenylindole (DAPI) in the mounting medium (Vector Laboratories). Images of spreaded cells were captured by a confocal microscope (Leica Microsystems), and the cell surface area was measured using MetaMorph software.
Cell migration assay
Cell migration assay was performed as previously described (6) using a modified Boyden chamber assay with Transwell inserts with 5.0-mm pore polycarbonate membrane. oxLDL (50 mg/ml) or native LDL (50 mg/ml)-treated or untreated macrophages were allowed to migrate for 15 hours at 37°C across the polycarbonate membrane. Migrated cells were fixed with 4% paraformaldehyde and stained with DAPI. The number of cells that migrated was counted from random fields under fluorescence microscopy.
Data analysis
Data are given as means ± SE. Statistical analysis was performed using the Student's t test (two-tailed, unpaired, and equal variance) for data with two groups. For data involving more than two groups, we performed ANOVA followed by Bonferroni's multiple comparison test using GraphPad Prism 5 software. Statistical significance was set at P < 0.05.
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